News

EpiCeram Combo Tx Shows Benefit for Atopic Dermatitis

Publish date: August 20, 2010

 

The study was funded by EpiCeram’s distributor, Promius Pharma LLC. Dr. Kircik and his associate Dr. Del Rosso are consultants and speakers for Promius Pharma. Dr. Kircik’s associate Daniel Aversa is a Promius Pharma employee. Dr. Simpson disclosed that he participated in research funded by Ceragenix Pharmaceuticals Inc., the original developer of EpiCeram.

Pages

Recommended Reading

ASCO: In the Pipeline: IL-21 Active in Metastatic Melanoma
MDedge Dermatology
Techniques Not Equal for Flattening Mohs Specimens
MDedge Dermatology
HPV+ Oropharynx Cancer Raises Sexual Partner's HPV Risk
MDedge Dermatology
Mohs Infection Rates Equal With Sterile Versus Clean Gloves
MDedge Dermatology
Frozen Sections for Mohs Surgery Can be Used to Treat Melanoma
MDedge Dermatology
Editorial Refutes EWG's Sunscreen Finding
MDedge Dermatology
Risk Factor Profiles Differ for Single vs. Multiple Basal Cell Carcinomas
MDedge Dermatology
PLX4032 Takes Aim at BRAF-Mutated Metastatic Melanoma
MDedge Dermatology
Oral Mucosal Melanoma of the Mandibular Gingiva: A Case Report
MDedge Dermatology
Underlying Amelanotic Lentigo Maligna Melanoma Uncovered After a Severe Blistering Sunburn [letter]
MDedge Dermatology